Showing results (41-50 of 98) with videos related to
Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
A group of genome-based biomarkers that add to a Kattan nomogram for predicting progression in men with high-risk prostate cancerPamela L Paris, Vivian Weinberg, Giancarlo Albo, et al.Cancer|December 22, 2005
Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinomaBrian I Rini, Vivian Weinberg, Sarah Dunlap, et al.BJU International|April 5, 2007
Evaluation and significance of circulating epithelial cells in patients with hormone-refractory prostate cancerJorge A Garcia, Jonathan E Rosenberg, Vivian Weinberg, et al.Brachytherapy|April 6, 2004
Managing nasopharyngeal carcinoma with intracavitary brachytherapy: one institution's 45-year experienceNancy Lee, Rex Hoffman, Theodore L Phillips, et al.Brachytherapy|September 27, 2005
Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancerI-Chow J Hsu, Alvin R Cabrera, Vivian Weinberg, et al.International Journal of Radiation Oncology, Biology, Physics|March 12, 2013
Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomesChien Peter Chen, Vivian Weinberg, Katsuto Shinohara, et al.International Journal of Radiation Oncology, Biology, Physics|June 9, 2004
A study of planning dose constraints for treatment of nasopharyngeal carcinoma using a commercial inverse treatment planning systemPing Xia, Nancy Lee, Yu-Ming Liu, et al.Cancer Research|July 5, 2002
Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapyKatherine A Rauen, Daniel Sudilovsky, Jason L Le, et al.International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experienceNancy Lee, Ping Xia, Jeanne M Quivey, et al.Blood|June 5, 2008
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashionBrian Kavanagh, Shaun O'Brien, David Lee, et al.Pageof 10